key: cord-0938494-x4m80wte authors: Mitra, Biswadev; Mitchell, Rob D; Cloud, Geoffrey C.; Stub, Dion; Nguyen, Minh; Nanayakkara, Shane; Miller, Jean‐Philippe; O'Reilly, Gerard; Smit, De Villiers; Cameron, Peter A. title: Presentations of stroke and acute myocardial infarction in the first 28 days following the introduction of state of emergency restrictions for COVID‐19 date: 2020-08-24 journal: Emerg Med Australas DOI: 10.1111/1742-6723.13621 sha: d50e093104162cd6118cc305555c8a7b6473e8b8 doc_id: 938494 cord_uid: x4m80wte OBJECTIVES: To determine if Victorian state of emergency (SOE) measures to combat COVID‐19 were associated with delayed presentations or management of acute stroke and acute myocardial infarction (AMI). METHODS: This was a retrospective, pre‐ and post‐implementation study using data from an adult, tertiary cardiology and neurosciences centre with 24‐hour capacity for endovascular procedures. All primary presentations with acute stroke or AMI during the first 28 days of Stage 2 and 3 SOE restrictions (26 March to 23 April 2020) were compared to an equivalent period without restrictions (26 March to 23 April 2019). The primary outcome variable was time from onset of symptoms to emergency department (ED) presentation. RESULTS: There were 52 (1.6% of all ED presentations) patients that met inclusion criteria during the SOE period and 57 (1.0%) patients in the comparator period. Patients were equally matched for demographics, disease severity and prior history of stroke or AMI. Median time from symptom onset to presentation was 227 (93‐1183) mins during the SOE period and 342 (119‐1220) mins during the comparator period (p=0.24). Among eligible patients with ischaemic stroke or ST‐elevation AMI, median time to primary reperfusion intervention was 65 (37‐78) mins during SOE and 44 (39‐60) mins in the comparator period (p=0.54). There were no differences in mortality at hospital discharge (9.6% vs 10.5%) and hospital LOS (5.4 vs 4.3 days). CONCLUSIONS: In the first 28 days, SOE measures to combat COVID‐19 were not associated with delays in presentation or life‐saving interventions for patients with acute stroke and AMI. This article is protected by copyright. All rights reserved. Coronavirus disease is caused by the SARS-Cov-2 virus, a potentially fatal disease that is of significant global public health concern. The outbreak was declared a pandemic on 11 March 2020. In order to combat community transmission of the virus, countries around the world have measures, individuals were only permitted to leave their place of residence for four reasons: to shop for essential supplies, to exercise, to work or study (if this cannot be done remotely), and to seek medical care. A potential adverse effect of physical distancing interventions, such as the Victorian SOE measures, is delayed assessment and management of non-COVID-19 conditions. Consistent with this, Victorian hospitals have reported decreases of up to 40% in emergency department (ED) attendance. (4) Contributing factors may include apprehension of patients to visit health services where patients with symptoms of COVID-19 are being assessed, delayed detection of symptoms and signs by family and friends, and misinterpretation of public health messaging to "stay at home". A shift to primary care being practised by telehealth (potentially resulting in sub-optimal assessment of patients), and reduced priority of regular health screening and risk factor assessment, may also be implicated. It has been repeatedly demonstrated that early recognition of symptoms with reduced time to intervention results in better outcomes following stroke and acute myocardial infarction (AMI). (5, 6) The aim of this study was to Accepted Article This article is protected by copyright. All rights reserved. determine whether there was an association of Victoria"s SOE measures with delayed presentations of acute stroke and AMI. Secondary aims were to assess the association between the implementation of SOE restrictions and times to essential investigation (computed tomography of the brain (CTB) for acute stroke), reperfusion interventions and hospital outcomes. A retrospective pre-and post-implementation study was undertaken. The study protocol was reviewed and approved by The Alfred Hospital Research and Ethics Committee (Project ID 245/20). The requirement to seek informed consent from patients was waived. The study was conducted at an adult major referral hospital in metropolitan Melbourne, Victoria, Australia with an annual ED attendance of approximately 65,000 patients. The Emergency and Trauma Centre (E&TC) is serviced by emergency physicians between the hours of 0700-0200 hrs on weekdays and 0700-2400 hrs on weekends. Patients presenting to the E&TC with symptoms consistent with stroke are managed by a multi-disciplinary team via a stroke call-out system. This includes a stroke consultant or registrar, a critical care registered nurse, an emergency medicine registrar or consultant and a pharmacist (in-hours). The system aims to facilitate rapid access to multi-modal CT imaging, including plain CTB, arch to vertex CT angiography and CT perfusion imaging using automated and standardised software reporting (Rapid©). Reperfusion strategies (thrombolysis and endovascular clot retrieval) are delivered according to a hospital protocol. All patients with ST-elevation myocardial infraction (STEMI) are managed through a STEMI call-out system. Patients are assessed by a critical care registered nurse, a cardiology registrar and emergency medicine registrar or consultant, with the objective of expediting reperfusion via percutaneous coronary intervention (PCI). PCI was the preferred therapy for STEMI patients and patients with STEMI were not expected to receive thrombolysis at this centre. This article is protected by copyright. All rights reserved. Participants: The exposed cohort were all primary presentations with acute stroke or AMI during the first 28 days of Stage 2 and 3 SOE restrictions (26 March 2020 to 23 April 2020). We included all patients who presented to hospital and were diagnosed with an ischaemic stroke or spontaneous intracerebral haemorrhage (excluding subarachnoid haemorrhage) and were managed by the acute stroke service. Patients diagnosed with a transient ischaemic attack were excluded. We also included all patients who were diagnosed with a STEMI or non-STEMI (NSTEMI) and managed by the cardiology service. Patients transferred from other hospitals and those presenting for ongoing management of previously diagnosed stroke or heart disease were excluded. Patients with stroke or AMI in the setting of a concurrent illnesses managed This article is protected by copyright. All rights reserved. Data extractions: Participants were identified from comprehensive databases maintained by the stroke and cardiology services. Data were augmented by review of electronic medical record using explicit chart review methods by two investigators (BM and JM). Additional explanatory variables assessed included mode of arrival to hospital, presenting complaint, whether the patient was managed as being COVID-suspect and severity of disease. To quantify severity of stroke, the first National Institutes of Health Stroke Scale (NIHSS) was used as recorded by the admitting stroke registrar or consultant. To quantify the severity of an AMI, the peak troponin level in the index presentation was used. Troponin concentrations are measured at The Alfred hospital using Architect STAT high sensitivity troponin I with a limit of detection of 1.9ng/L, and a CV of 12.6% has been reported at 3.5 ng/L. (7) Data on COVID-19 testing were extracted from the COVED registry. (8) Afterhours was defined as the period between 18:00 and 07:00, 7 days a week. (9) Analysis: Continuous and normal or near-normally distributed variables were summarised using mean (standard deviation) with differences assessed using Student"s t-test. Skewed continuous and ordinal variables were summarised using median (inter-quartile range; IQR) and differences assessed the Wilcoxon rank-sum test. Nominal variables were summarised using counts (proportions) and differences assessed using the chi-square test or, if a value in a cell was <5, Fisher"s exact test was used. A p-value of <0.05 was defined to be statistically significant. Assuming that among patients presenting without delay of >12 hours from onset of symptoms, time to presentation was 200 (30) mins, to test for a minimum clinically significant 10% difference, with 90% power, we required 48 patients in each arm with a minimum sample size of 96. All analyses were undertaken using Stata v 15.1 (College Station, Texas, USA). Table 2 . The effects of the SOE through significant restrictions on individual movement has been associated with controlling the spread of COVID-19. In the first 28 days of restrictions, we observed a reduction in the number of presentations of acute stroke and AMI, but there appeared to be no significant adverse Similarly, a 38% reduction in cardiac catheterisation laboratory STEMI activations were observed in the USA, and a 40% reduction in Spain. (11, 12) Authors suggested that explanations may include avoidance of medical care due to physical distancing rules or concerns of contracting COVID-19 in hospital, and reduction in STEMI misdiagnosis. Times to early life-saving interventions were unchanged in this study. This contrasts with experience overseas, where times were likely to have been affected by the greater burden of COVID-19 than experienced in Australia to date. Centres from Italy have reported longer onset-to-door and door-totreatment times for major strokes in the setting of the COVID-19 pandemic. (13) Similarly, in Hong Kong, longer median times for symptom onset to first medical contact, door to device and catheterisation laboratory Accepted Article This article is protected by copyright. All rights reserved. arrival to device times were observed in STEMI patients when compared with historical data from the prior year. (14) Based on this evidence, investigators have recommended health authorities promote early presentations for AMI compatible symptoms and no delays for reperfusion treatment. (15, 16) While no significant differences were observed in this study, one plausible explanation for potential delays in door-to-treatment times may relate to COVID-19 infection prevention and control (IPC) requirements, including the requirement for staff to don personal protective equipment (PPE). Very few catheterisation laboratories are equipped with negative ventilation systems and, consequently, the risk of transmission remains relatively high with each encounter.(17) Tailored management protocols (including IPC and PPE procedures) have been developed, but implementation may have the effect of delaying time-to-treatment. (18, 19) This study is limited in being retrospective and can therefore only imply association. It is subject to the established limitations of medical record review methodology. (20) Only a short period of 28 days of post-implementation data were analysed and may not be representative over a longer period of time. However, all patients in both periods were available for analysis and presents valuable data on early effects of the SOE. Pre-hospital deaths were unaccounted for in this study design, and review of coronial records may add further information to potential adverse effect of physical distancing. In addition, the study was not designed to explore the reasons for delayed presentations. Small numbers in sub-group analyses may be associated with Type II errors and require ongoing surveillance. For example, the difference in median time to reperfusion of 21 minutes is clinically significant, but due to the small number of patients, we cannot be confident that the true population difference is reflected in this sample. Being a single centre study and limited to two conditions only, generalisability to other health services and other conditions remains unknown. Variations in demographics and population of selected patients, together with small samples, may explain differences observed in other health services. (21) Accepted Article This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved. Accepted Article This article is protected by copyright. All rights reserved. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study The Effectiveness of Social Distancing in Mitigating COVID-19 Spread: a modelling analysis State of Emergency restrictions on presentations to two Victorian emergency departments ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study Informing emergency care for COVID-19 patients: The COVID-19 Emergency Department Quality Improvement Project protocol After-hours" staffing of trauma centres and outcomes among patients presenting with acute traumatic coagulopathy The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic Acute stroke management pathway during Coronavirus-19 pandemic Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circulation Cardiovascular quality and outcomes Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. Rev Espanola De Cardiologia How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People"s Hospital. Intensive Care Medicine Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC's Interventional Council and SCAI COVID-19 Pandemic and Acute Myocardial Infarction: Management Protocol From A British Cardiac Centre Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic. Stroke The quality of medical record review studies in the international emergency medicine literature Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation Informing emergency care for all patients: The Registry for Emergency Care (REC) Project protocol Effects of Response to Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa CoHERE-a call for a post-pandemic health strategy Mitigating the wider health effects of covid-19 pandemic response Accepted Article This article is protected by copyright. All rights reserved. Accepted Article